Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: A prospective study

European Journal of Haematology

Volumn 60, Issue 3, 1998, Pages 166-171

  Enblad, Gunilla ^a   Hagberg, Hans ^a   Gustavsson, Anita ^b   Glimelius, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hodgkin's disease; MIME; Relapse; Treatment

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; MITOGUAZONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MUSCLE WEAKNESS; PRIORITY JOURNAL; SALVAGE THERAPY; SKIN MANIFESTATION; SWEDEN; THROMBOCYTOPENIA;

EID: 0031918129     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01018.x     Document Type: Article

References (17)

1. CANELLOS GP. Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Oncol 1990: 2(suppl 1): 1-8.
2. LONGO DL, DUFFEY PL, YOUNG RC, et al. Conventionaldose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1992: 10: 210-218.
3. Fox KA, LIPPMAN SM, CASSADY JR, HEUSINKVELD RS, MILLER TP. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. J Clin Oncol 1987: 5: 38-45.
4. BRADA M, EELES S, ASHLEY S, NICHOLS J, HORWICH A. Salvage radiotherapy in recurrent Hodgkin's disease. Ann Oncol 1992: 3: 131-135.
5. LEIGH BR, Fox KA, MACK CF, BAIER M, MILLER TP, CASSADY JR. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 1993: 27: 855-862.
6. VIVIANI S, SANTORO A, NEGRETTI E, BONFANTE V, VALAGUSSA P, BONADONNA G. Salvage chemotherapy in Hodgkin's disease. Ann Oncol 1990: 1: 123-127.
7. URBA WJ, LONGO DL. Hodgkin's disease. N Engl J Med 1992: 326: 678-687.
8. PFREUNDSCHUH MG, SCHOPPE WD, FUCHS R, PFLÜGER KH, LOEFFLER M, DIEHL V. Lomustine, etoposide, vindesine, and dexametasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine and prednisone (COPP) and doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD): a multicenter trial of the German Hodgkin study group. Cancer Treat Rep 1987: 71: 1203-1207.
9. SANTORO A, VIVIANI S, VALAGUSSA P, BONFANTE V, BONADONNA G. CCNU, etoposide and prednimustine (CEP) in refractory Hodgkin's disease. Semin Oncol 1986: 13: 23-26.
10. FERMÉ C, BASTION Y, LEPAGE E, et al. The MINE-regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol 1995: 6.543-549.
11. HAGEMEISTER FB, TANNIR N, MCLAUGHLIN P. et al. MIME chemotherapy (methyl-gag, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease. J Clin Oncol 1987: 5.556-561.
12. ENBLAD G, GLIMELIUS B, HAGBERG H, LINDEMALM C. Methyl-gag, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. Acta Oncol 1990: 29: 297-301.
13. ENBLAD G, HAGBERG H, GLIMELIUS B. Methyl-gag, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas. Acta Oncol 1996: 35: 165-170.
14. CARBONE PP, KAPLAN HS, MUSSHOF K, SMITHERS DW, TUBIANA M. Report on the committee on Hodgkin's disease staging. Cancer Res 1971: 31: 1960-1961.
15. GLIMELIUS B, ENBLAD G, KALKNER M, et al. Treatment of Hodgkin's disease: the Swedish National Care Programme experience. Leuk Lymph 1996: 21: 71-78.
16. BIERMAN PJ, ANDERSON JR, FREEMAN MB, et al. High-dose chemotherapy followed by autologous haematopoietic resue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol 1996: 7: 151-156.
17. LINCH DC, WINFIELD D, GOLDSTONE AH, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 1993: 341: 1051-1054.